Psichiatria
RECOVER trial suggests vagus nerve stimulation benefits some patients with severe treatment-resistant depression for at least two years
Riportato dall'IA Immagine generata dall'IA Verificato
An implanted device that stimulates the vagus nerve was associated with sustained improvements in symptoms, functioning and quality of life among adults with long-standing, treatment-resistant major depression, according to researchers reporting two-year follow-up data from the ongoing RECOVER study led by Washington University School of Medicine in St. Louis.
Carmen Prada, responsabile della salute mentale presso l'ospedale Reina Sofía di Córdoba, ha testimoniato giovedì in tribunale che il suo paziente, Francisco Miguel León Benítez, non aveva intenzioni suicide quando è deceduto nel 2020. L'accusa chiede quattro anni di reclusione, mentre la parte civile ne richiede otto per due omicidi colposi, incluso quello di un uomo ucciso dal paziente nel 2015. La famiglia accusa il medico di non aver disposto il trattamento sanitario obbligatorio nonostante le ripetute richieste dal 2010.
Riportato dall'IA
Uppsala county's psychiatric ambulance, operating only eight hours a day, misses 60 to 80 percent of mental health alarms due to resource shortages. Hospital board chair Neil Ormerod (V) wants to extend operating hours but lacks funding. Police report a clear difference when the service is active.
A new psychiatric diagnosis aims to identify a forgotten patient group fearing they disgust others with their smell. This results in unnecessary washing of clean clothes. The condition, known as ORD, stems from a constant pursuit of freshness.
Riportato dall'IA
Scientists from Sweden, Denmark, and Germany have created a genetic test using polygenic risk scores to help predict which antidepressants and anti-anxiety medications will work best for individuals. The approach, tested on research databases, could reduce the trial-and-error process that affects nearly half of patients with depression or anxiety. Lead researcher Professor Fredrik Åhs envisions a future with cheap, effective tests to speed up relief for millions.